Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial

Metastatic Breast ◽

Efficacy And Safety ◽

Double Blind ◽

S5-5: A Phase III, Randomized, Double-Blind, Placebo-Controlled Registration Trial To Evaluate the Efficacy and Safety of Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Patients with Previously Untreated HER2−Positive Metastatic Breast Cancer (CLEOPATRA).

10.1158/0008-5472.sabcs11-s5-5 ◽

2011 ◽

Cited By ~ 3

Author(s):

J Baselga ◽

S-B Kim ◽

S-A Im ◽

R Hegg ◽

Y-H Im ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Efficacy And Safety ◽

Her2 Positive ◽

Double Blind ◽

Double Blind Placebo ◽

Registration Trial

RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab In Combination with Chemotherapy for Second-Line Treatment of HER2-Negative Metastatic Breast Cancer.

10.1158/0008-5472.sabcs-09-42 ◽

2009 ◽

Cited By ~ 33

Author(s):

A. Brufsky ◽

I. Bondarenko ◽

V. Smirnov ◽

S. Hurvitz ◽

E. Perez ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Line Treatment ◽

Second Line ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial

Advances in Integrative Medicine ◽

10.1016/j.aimed.2022.01.002 ◽

2022 ◽

Author(s):

Benyamin Pazoki ◽

Nadia Zandi ◽

Zeinab Assaf ◽

Hossein Sanjari Moghaddam ◽

Arefeh Zeinoddini ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder

Efficacy and Safety of a Standardized Soy and Hop Extract on Menopausal Symptoms: A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

The Journal of Alternative and Complementary Medicine ◽

10.1089/acm.2021.0027 ◽

2021 ◽

Author(s):

Hye In Kim ◽

Min Kyoung Kim ◽

Inha Lee ◽

Jisun Yun ◽

Eui Hyeok Kim ◽

...

Keyword(s):

Clinical Trial ◽

Menopausal Symptoms ◽

Efficacy And Safety ◽

Double Blind ◽

Efficacy and safety of a standardized extract from Achillea wilhelmsii C. Koch in patients with ulcerative colitis: A randomized double blind placebo-controlled clinical trial

Complementary Therapies in Medicine ◽

10.1016/j.ctim.2019.05.001 ◽

2019 ◽

Vol 45 ◽

pp. 262-268 ◽

Cited By ~ 2

Author(s):

Mahtab Amiri ◽

Jafar Navabi ◽

Yalda Shokoohinia ◽

Fatemeh Heydarpour ◽

Gholamreza Bahrami ◽

...

Keyword(s):

Ulcerative Colitis ◽

Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Achillea Wilhelmsii

Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial

Complementary Therapies in Medicine ◽

10.1016/j.ctim.2019.102205 ◽

2019 ◽

Vol 47 ◽

pp. 102205 ◽

Cited By ~ 3

Author(s):

Mohammadreza Rafati ◽

Arash Ghasemi ◽

Majid Saeedi ◽

Emran Habibi ◽

Ebrahim Salehifar ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Nigella Sativa ◽

Acute Radiation ◽

Radiation Dermatitis ◽

Double Blind ◽

Efficacy and safety of CAEC (Canavalia gladiata arctium lappa extract complex) on immune function enhancement: An 8 week, randomised, double-blind, placebo-controlled clinical trial

Journal of Functional Foods ◽

10.1016/j.jff.2020.104259 ◽

2020 ◽

Vol 75 ◽

pp. 104259

Author(s):

Yee Ran Lyu ◽

Sol-ji Jung ◽

Su-Won Lee ◽

Won-Kyung Yang ◽

Seung-Hyung Kim ◽

...

Keyword(s):

Clinical Trial ◽

Immune Function ◽

Efficacy And Safety ◽

Double Blind ◽

Arctium Lappa ◽

Double Blind Placebo ◽

Canavalia Gladiata

Cardiac Tolerability of Pertuzumab Plus Trastuzumab Plus Docetaxel in Patients With HER2‐Positive Metastatic Breast Cancer in CLEOPATRA: A Randomized, Double‐Blind, Placebo‐Controlled Phase III Study

The Oncologist ◽

10.1634/theoncologist.2012-0448 ◽

2013 ◽

Vol 18 (3) ◽

pp. 257-264 ◽

Cited By ~ 86

Author(s):

Sandra M. Swain ◽

Michael S. Ewer ◽

Javier Cortés ◽

Dino Amadori ◽

David Miles ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Her2 Positive ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study

SOLTI-0701: A Multinational Double-Blind, Randomized Phase 2b Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo When Administered in Combination with Capecitabine in Patients with Locally Advanced or Metastatic Breast Cancer (BC).

10.1158/0008-5472.sabcs-09-45 ◽

2009 ◽

Cited By ~ 19

Author(s):

J. Baselga ◽

H. Roché ◽

F. Costa ◽

J. Getúlio Martins Segalla ◽

H. Pinczowski ◽

...

Keyword(s):

Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Double Blind

A Double-Blind, Randomized, Placebo-Controlled, Phase 2b Study Evaluating the Efficacy and Safety of Sorafenib (SOR) in Combination with Paclitaxel (PAC) as a First-Line Therapy in Patients (pts) with Locally Recurrent or Metastatic Breast Cancer (BC).

10.1158/0008-5472.sabcs-09-44 ◽

2009 ◽

Cited By ~ 23

Author(s):

W. Gradishar ◽

V. Kaklamani ◽

T. Prasad Sahoo ◽

D. Lokanatha ◽

V. Raina ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Efficacy And Safety ◽

First Line ◽

Double Blind ◽

First Line Therapy ◽

Line Therapy ◽

Locally Recurrent